Citigroup Inc Longeveron Inc. Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding LGVN
# of Institutions
2Shares Held
1.18KCall Options Held
0Put Options Held
0About Longeveron Inc.
- Ticker LGVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,925,940
- Market Cap $12.3M
- Description
- Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...